Kemnay Advisory Services Inc.
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1555283
New York, NY
Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,029,118
+$549,557 QoQ
Shares Held
37,955
+1.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
2.78%
of 13F equity value
Holder Rank
#489
of 2,606 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Kemnay Advisory Services Inc. holds $29,617,086 across 14 Diagnostics & Research names. TMO ranks #1 (64.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
37,955 | $19,029,118 | |
| 2 | DHR |
Danaher Corp /De/
|
54,382 | $10,358,683 | |
| 3 | TWST |
Twist Bioscience Corp
|
549 | $56,481 | |
| 4 | VCYT |
Veracyte, Inc.
|
711 | $41,757 | |
| 5 | GRAL |
GRAIL, Inc.
|
353 | $24,099 | |
| 6 | RDNT |
RadNet, Inc.
|
318 | $19,611 | |
| 7 | GH |
Guardant Health, Inc.
|
116 | $17,403 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
33 | $17,372 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,029,118 | 37,955 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,479,561 | 37,596 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,264,917 | 40,150 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,361,998 | 39,920 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,185,963 | 39,920 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,849,731 | 33,862 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,242,454 | 25,455 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,960,832 | 16,103 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,256,441 | 7,697 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||